The Golden Mean: Why Increasing Healthspan Is the Evolution of Medicine

A Clinical Philosophy for the Space Between Managed Disease and Flourishing

By Shaun Menashe, LAc, MTOM, Dipl. O.M. | Golden Mean Acupuncture, Los Angeles

It is common for patients to leave a medical appointment having been told everything is normal. The result is reassuring. What it does not establish is whether the patient is genuinely healthy or simply not yet measurably ill. In-range laboratory values confirm the absence of diagnosable pathology. They do not assess whether the patient is physiologically prepared for the cumulative demands of aging, nor do they account for the lived experience of health that the patient brought into the room.

This is a structural feature of modern medicine: identifying and treating illness once it has become overtly measurable. It is a system oriented toward reaction rather than anticipation. No strategy is offered for cultivating resilience before pathology or age-related physiological decline becomes the dominant clinical narrative. The clinical encounter ends where the diagnostic framework ends.

The persistence of symptoms in the absence of clear pathology is a structural blind spot of reactive medicine. This gap extends to the broader challenge of anticipating physiological change before it becomes diagnostic, and to the silent weight of environmental, hormonal, and lifestyle factors that compound across decades without breaching standard clinical thresholds.

Lifespan measures the duration of a life. Healthspan measures the proportion of that life spent in genuine functional health, with intact cognitive capacity, physical resilience, metabolic stability, and the physiological reserves required to meet the demands of aging without systemic breakdown. The two are not synonymous, and modern medicine has been considerably more successful at extending one than preserving the other. A life prolonged by the management of established disease is not the same clinical outcome as a life in which the conditions for disease were never allowed to consolidate. That distinction is not semantic. It points toward an entirely different clinical project: not the earlier detection of pathology, but the proactive architecture of the biological resilience that a full healthspan depends on.

Key Takeaways

• Western medicine excels at acute care, crisis intervention, diagnostics, and pharmaceutical management of serious disease; these achievements are real, irreplaceable, and form the safety floor of all responsible healthcare

• Modern medicine has extended lifespan significantly, but extending healthspan, the years lived in genuine functional health rather than in the management of established disease, requires a different set of clinical questions

• Many commonly used interventions in chronic care are designed to manage or modulate disease activity rather than fully resolve underlying contributors, which is an appropriate function of those tools and also a structural limitation

• Some patients continue to experience symptoms despite values within standard reference ranges, reflecting the difference between population norms and individual physiology

• Traditional Chinese Medicine asks a structurally different clinical question than western diagnostic medicine: not what disease is present, but what pattern of imbalance is generating the presentation

• The strongest evidence for integrative approaches such as acupuncture is in chronic pain and nervous system conditions, with emerging research in other chronic and inflammatory presentations

• Integrative care at Golden Mean works alongside conventional medicine, not in opposition to it; the goal is to address the terrain that standard care does not reach

A Framework for Patients Who Have Run Out of Answers

The patients who arrive at integrative care have often already navigated the conventional system thoroughly. Tests have been run, diagnoses considered, and treatments prescribed. What brings them to a different conversation is not a rejection of that process but the recognition that it has reached a therapeutic ceiling. Their lived experience remains unresolved. No strategy has been offered for what comes next. The question of how to build and maintain functional health across a lifespan, rather than simply respond to its deterioration, is one the standard clinical encounter was not designed to ask.

The Case for Western Medicine Is Strong

Western medicine is one of the most consequential achievements in human history. The capacity to intervene in acute crisis, to image, biopsy, and sequence, and to deploy targeted pharmaceutical agents against infection, autoimmunity, and malignancy, has redefined human survival. This is the foundation on which all responsible healthcare conversation rests.

Western Medicine's Defining Strength

Emergency medicine, trauma surgery, intensive care, and infectious disease management represent the clearest expression of western medical breakthrough. No integrative framework competes in this domain. When the body is in acute crisis, the tools of crisis medicine are the correct tools.

Objective Measurement and Diagnostics Transformed the Understanding of Disease

Western Analytical Tools Have Strengthened the Evidence Base for Integrative Medicine

The capacity to measure, image, and quantify has transformed the understanding of disease. Diagnostic imaging, inflammatory biomarker analysis, and peer-reviewed clinical methodology have produced a body of evidence that no previous era of medicine could have generated. These tools have also done integrative medicine a significant service. Clinical systems developed over centuries of observation, often articulated in philosophical and classical frameworks, can now be examined through the same analytical infrastructure that western science uses to validate its own interventions. The research supporting acupuncture's role in chronic painandnervous system regulation is itself a product of that convergence, ancient clinical observation examined through modern scientific instrumentation. The diagnostic infrastructure of western medicine is not something integrative practice works around. It is something integrative practice depends on.

Pharmaceutical Medicine Has Extended Lifespan at a Scale No Other System Has Matched

Insulin for type 1diabetes. Antiretrovirals for HIV. Biologics for severe autoimmune disease. Immunosuppressants for organ transplant. These represent real, irreplaceable tools that have extended lifespan at a scale that no other intervention model has matched. The integrative conversation begins after those tools have been appropriately deployed, never instead of them. What it adds is the clinical attention to the upstream terrain those tools do not address: the hormonal environment, the inflammatory load, the metabolic and nervous system conditions that determine how well a patient lives within the years that medicine has helped extend.

Where Diagnostic Medicine Reaches Its Ceiling

Every system is built to solve specific problems. The structural limitations of western medicine are not failures of intention. They are the natural consequence of building a system around particular goals, and they become visible at the edges of those goals. Where the western analytical framework excels at identifying established pathology, it was not designed to characterize the functional terrain that precedes it. That is precisely where the proactive architecture of healthspan begins.

The Diagnostic Threshold Leaves a Significant Category of Patients Without a Path Forward

Western medicine is organized around diagnosis. A clinical presentation becomes actionable when it crosses a threshold defined by population-level reference ranges. Below that threshold, the system has limited tools. Some patients experience symptoms despite values within standard ranges, reflecting the genuine difference between what is normal for a population and what is optimal for an individual. It is a structural feature of how diagnostic medicine was built, and it creates a category of patient experience the system was not designed to address.

This gap is particularly evident in presentations involving subclinical thyroid function, early nervous system dysregulation, and low-grade inflammatory patterns that compound over time without breaching standard clinical thresholds. These are not obscure edge cases. They represent a substantial and underserved patient population whose physiological displacement is real, progressive, and addressable, provided the clinical framework being applied is oriented toward anticipation rather than reaction.

The scope of undetected pathology is also shaped by the economics of standard care. Insurance-covered and fee-for-service laboratory panels are designed around cost efficiency and population-level screening, not individual physiological optimization. The result is a diagnostic picture that is broad but often insufficiently deep. Anemia provides a useful illustration: copper plays a central role in hemoglobin synthesis and iron absorption, and disruptions in copper metabolism, whether from dietary deficiency, zinc excess, or impaired absorption, can compromise red blood cell production before standard complete blood count values shift into flagged ranges (Wahab et al., 2020; PMC, 2025). By the time the CBC reflects a problem, the underlying metabolic disruption has often been active for months or longer. The markers that would have revealed it earlier, serum copper, ceruloplasmin, and zinc-copper ratios, are not part of routine screening. They require a clinician oriented toward the upstream question to order them at all.

Symptom Modulation in Chronic Disease Addresses the Expression, Not Always the Driver

Many commonly used interventions in chronic disease management are designed to modulate symptoms and disease activity rather than fully resolve underlying contributors. NSAIDs reduce inflammatory signaling without addressing what is generating the inflammation. SSRIs modulate serotonergic signaling and can meaningfully improve mood and resilience, but they do not directly address all upstream contributors such as chronic stress load, sleep disruption, or autonomic imbalance.

The limitation arises when symptom modulation is offered as a complete clinical response to a condition whose primary drivers remain active. Initiating symptom-level care is appropriate and often vital, particularly where a slower approach of lifestyle modification alone would result in meaningful decline in quality or duration of life. That clinical necessity does not, however, resolve the need to identify and address the primary drivers of pathology. Long-term pharmaceutical use carries its own physiological costs, and resolving the underlying contributors to a condition can, in many cases, reduce both the dosage and the duration of intervention required.

GLP-1 receptor agonists illustrate this tension precisely. These medications have demonstrated meaningful efficacy in weight reduction and metabolic regulation, and for patients where obesity or metabolic dysfunction represents an acute risk, they are appropriate and sometimes necessary. What they do not address are the dietary patterns, trauma history, sleep disruption, stress physiology, and sedentary behavior that generated the metabolic dysfunction in the first place. When the pharmacological effect becomes a substitute for that upstream work rather than a bridge toward it, the underlying drivers remain active and the question of long-term healthspan goes unanswered.

A treatment ceiling is not a clinical failure. It is the point at which a different set of questions becomes necessary. In some conditions, pharmaceutical intervention begins at that ceiling rather than arriving at it gradually. The medication is appropriate, the diagnosis is correct, and the clinical conversation has nonetheless ended at precisely the moment the deeper questions about function, resilience, and long-term healthspan become pertinent. The difference between a life that is medically managed and a life in which the underlying regulatory systems are functioning well is, in practical terms, the difference between lifespan and healthspan.

The Golden Mean as a Clinical Analogy for Physiological Resilience

In the Nicomachean Ethics, Aristotle proposed that virtue and flourishing exist as the precise midpoint between two failure states. Courage is the mean between cowardice and recklessness. The analogy to physiology is imperfect but instructive. The autonomic nervous system operates on a spectrum between chronic hyperactivation and functional shutdown. The immune system calibrates between insufficient response and chronic overactivation. The endocrine system cycles through phases that require dynamic balance rather than static correction. In each case, resilience tends to emerge not at either extreme but in the adaptive range between them.

Physiological resilience is not the absence of stress. It is the capacity to meet a stressor, respond appropriately, and return to baseline. A nervous system fixed in chronic activation and one fixed in depletion and shutdown represent opposite displacements from that range, and both compromise healthspan in distinct but equally significant ways. Health, in this framework, is not the absence of disease. It is the active state in which the body's regulatory systems remain calibrated to meet demand without systemic breakdown.

The overtraining athlete and the patient deconditioned by prolonged sedentary stress may present with overlapping symptoms: fatigue, disrupted sleep, and systemic inflammation. The biological states are different. The interventions required are different. What they share is a displacement from the individual's functional range, in opposite directions. The clinical question is not simply what is wrong. It is where the system has moved relative to where it functions well.

The Optimal Balance Point Is Unique to Each Individual

What constitutes resilience for one person may represent excess or deficiency for another. A cortisol pattern that is unremarkable in one individual may be pathologically suppressed in another. A thyroid value within population norms may represent a meaningful functional deficit for a specific patient. The clinical task is not to match a patient to a population average. It is to identify their individual functional range and the direction and degree of their displacement from it.

This is precisely the clinical problem that Traditional Chinese Medicine was built to solve, developed over centuries of observation before the laboratory tools to quantify individual variation existed. TCM's diagnostic model does not ask which disease is present. It asks what the system is doing, identifying patterns of imbalance rather than disease categories, and recognizing that two patients presenting with identical symptoms may reflect entirely different underlying displacements requiring entirely different interventions. That orientation is increasingly convergent with what western research is discovering about individual variation in nervous system function, immune response, and hormonal physiology. Research suggests acupuncture may influence nervous system regulation through mechanisms that western instrumentation can now measure, including autonomic balance, neurochemical signaling, and endogenous opioid release, with the strongest human evidence in chronic pain and certain nervous system conditions (Vickers et al., 2018; McDonald, 2025). The ancient clinical system and the modern analytical framework are describing overlapping terrain. That convergence is what makes the integrative position intellectually coherent rather than merely optimistic.

Integrative Care in Practice: From Ceiling to Cultivation

When standard evaluation has been completed and findings are unremarkable, integrative assessment begins from a different clinical orientation. The focus shifts from confirming the absence of diagnosable disease to characterizing the functional picture: the pattern of symptoms, the state of regulatory systems, and the degree of displacement from the individual's baseline. It is a different diagnostic aim applied to the same patient.

The same applies where a diagnosis has already been made and pharmaceutical intervention is underway. A patient managing a chronic condition with medication has not necessarily resolved the upstream contributors to that condition. The inflammatory drivers, the autonomic dysregulation, the metabolic or hormonal terrain that generated the pathology, remain active unless directly addressed. The rheumatoid arthritis patient on biologics whose inflammatory markers are controlled but whose fatigue and sleep disruption persist, and the hypothyroid patient on levothyroxine whose TSH has normalized but whose cognitive function and energy have not returned, both represent presentations where conventional medicine has done its job appropriately and the upstream clinical work remains. Acupuncture, herbal medicine, nutritional guidance, and mind-body support each address aspects of that terrain with a legitimate and developing evidence base.

The strongest case for integrative care, however, is not in the management of established disease but in the period before diagnostic thresholds are crossed. Subclinical functional changes are often identifiable through TCM pattern assessment and emerging functional markers before pathology has declared itself. Restoring regulatory resilience at that stage is considerably more efficient than intervening after chronic disease has developed. The anticipation of physiological change, and the active addressing of its upstream contributors, is the practical expression of a clinical orientation built around healthspan rather than disease management. A system organized around reaction will always arrive after the fact. The absence of diagnosed disease is not the endpoint of clinical attention. It is the optimal condition under which the most consequential work begins.

The Case for Not Waiting: Health as Cultivation, Not Crisis Response

A seed carries within it the full potential of the plant it could become. Whether that potential is realized depends entirely on the conditions surrounding it. Given adequate soil, water, and light, the seed sprouts. Removed from those conditions, it remains inert. It has not become something different. It has simply been denied what it required.

The same logic applies to human health. The absence of diagnosed disease does not mean the conditions for health are present. It means the threshold for measurable pathology has not yet been crossed. These are not the same clinical reality. A person can be free of diagnosable illness and simultaneously be living in a physiological environment that is actively working against their long-term function: chronically elevated stress hormones, disrupted sleep architecture, a gut microbiome compromised by decades of dietary pattern, an inflammatory load accumulating from environmental exposures that western science has not yet fully characterized. The seed is in the water but not in the soil. The conditions are partial, and the outcome is accordingly diminished.

This is not a theoretical concern. The epidemiological shift in chronic and malignant disease reflects precisely this dynamic at a population level. The environmental conditions surrounding human biology have changed faster than the scientific frameworks designed to measure their consequences. The latency between exposure and clinical expression is long. The diagnostic response arrives after the fact. And the individual patient, navigating that environment every day, is not well served by a clinical framework that waits for pathology to declare itself before asking what might be done.

The work of integrative care at this level is not treatment. It is cultivation. It means assessing the full ecology of the patient's life and identifying the degree to which those conditions are either supporting or undermining the biological resilience that healthspan depends on. The patient is not a closed system. They are in continuous relationship with everything that surrounds them, and the clinical picture cannot be understood in isolation from that context.

The case for not waiting is not a case for anxiety or hypervigilance about health. It is a case for the same kind of deliberate attention that any cultivator brings to the conditions under which something is trying to grow. The absence of a visible problem is not a reason to stop tending the soil. It is the optimal moment to do so.

Flourishing as an Active Practice

Aristotle's concept of eudaimonia, flourishing, describes an ongoing practice of calibration rather than a state to be achieved and held. Healthspan, understood properly, is not a metric. It is the lived experience of a system that remains resilient, adaptive, and functional across the arc of a life.

Building the biological conditions for wellness and longevity is a fundamentally different clinical project than managing the consequences of their absence. A diet oriented toward the active support of gut integrity, hormonal balance, immune regulation, and cellular resilience operates from an entirely different clinical premise than one organized around harm reduction.

The epidemiological picture of chronic and malignant disease is shifting. Cancer is presenting earlier and across a broader demographic and the contributors are not yet fully characterized. The latency between exposure and clinical expression will always exceed the scientific response time. Establishing a different physiological floor, one defined by proactive and constructive change, is the most meaningful form of harm reduction available.

A true Golden Mean: not merely the absence of disease, but the active cultivation of the resilience required to flourish.

For patients in Echo Park, Silver Lake, and the surrounding neighborhoods navigating the space between a normal lab result and actually feeling well, an initial consultation is where that process begins.

FAQ

• Does Golden Mean Acupuncture work alongside conventional medical treatment? 

  Golden Mean operates as a complement to conventional care, not a replacement for it. Patients are encouraged to maintain existing medical relationships and share any supplement or herbal protocols with their prescribing physicians.

• What does the first intake at Golden Mean involve?

  A detailed review of health status, symptom history, lifestyle, and existing diagnoses, combined with TCM pattern assessment. From that picture, a treatment approach is proposed that integrates the most relevant available tools.

• How does TCM diagnosis differ from a western medical diagnosis?

  Western diagnosis identifies disease against population-level standards. TCM pattern differentiation assesses the functional state of the individual's systems, asking what the system is doing rather than what disease it has. Both approaches are useful. They are asking different questions.

• What is Acupuncture's Role When Tests Are Normal but Symptoms Persist?

  Normal results indicate diagnostic thresholds have not been crossed. They do not confirm optimal function. TCM assessment is designed to characterize the functional picture that standard evaluation does not capture.

• How Does the Golden Mean Approach Apply in Clinical Practice?

  The clinical goal is calibration rather than suppression, resilience rather than the silencing of symptoms, and the restoration of the individual's own regulatory capacity. It means asking not only whether disease is present but whether the patient is flourishing across their full healthspan.

References

Aristotle. Nicomachean Ethics. Translated by W.D. Ross. Oxford University Press; 1998.

McDonald JL. Efficacy, safety and mechanisms of acupuncture and electroacupuncture for pain: a narrative review. Medical Research Archives. 2025. https://esmed.org/MRA/mra/article/view/6871

Ross et al. Brain fog: definitions, mechanisms, and measurement. Trends in Neurosciences. 2025. https://doi.org/10.1016/j.tins.2025.01.003

Smith-Ryan AE, DelBiondo GM, Brown AF, et al. Creatine in women's health: bridging the gap from menstruation through pregnancy to menopause. J Int Soc Sports Nutr. 2025;22(1):2502094. https://doi.org/10.1080/15502783.2025.2502094

Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain. 2018;19(5):455-474. https://doi.org/10.1016/j.jpain.2017.11.005

Yale Journal of Biology and Medicine. Introduction: integrative medicine. Yale J Biol Med. 2024;97(3). https://pmc.ncbi.nlm.nih.gov/articles/PMC11426301/

Wahab A, Bhatt H, et al. Zinc-induced copper deficiency, sideroblastic anemia, and neutropenia: a perplexing facet of zinc excess. Clin Case Rep. 2020;8(9):1666-1669. https://doi.org/10.1002/ccr3.2987

Korovljev D, et al. Anemia due to unexpected zinc-induced copper deficiency. Hematol Rep. 2025;17(4):35. https://www.mdpi.com/2038-8330/17/4/35

This article is for educational purposes only and does not replace medical advice from a primary care physician or specialist.